A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week. The diagnostic tool, the Elecsys pTau 181 plasma test, is developed by ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

For decades, confirming Alzheimer’s disease has meant invasive spinal taps, expensive brain scans, and, too often, waiting until memory loss is unmistakable. Now researchers and regulators are ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and ...